Cytokinetics, Incorporated
(CYTK - NASDAQ)
62,82 USD
📋 Profilo Aziendale

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases.

|